Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 20Withdrawn 2Unknown 1Terminated 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Dermatologic 1

Conditions

Prostatic Neoplasms 10Lymphoma, Large B-Cell, Diffuse 9Lymphoma 9Lymphoma, Follicular 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Mantle-Cell 3Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Anaplastic 2Leukemia 2Immunoblastic Lymphadenopathy 2Dendritic Cell Sarcoma, Interdigitating 2Burkitt Lymphoma 2Waldenstrom Macroglobulinemia 1Sezary Syndrome 1Recurrence 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Mycosis Fungoides 1Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 1Melanoma 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Primary Effusion 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell, Marginal Zone 1Lung Neoplasms 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Fibrolamellar hepatocellular carcinoma 1

Interventions

Cyclophosphamide 5Cytarabine 4Peripheral Blood Stem Cell Transplantation 3Etoposide 3fludarabine phosphate 2denileukin diftitox 2brigatinib 2Vincristine 2Rituximab 2Radiotherapy 2Prednisone 2Pentetic Acid 2Methotrexate 2Doxorubicin 2Brentuximab Vedotin 2sargramostim 1sapanisertib 1iratumumab 1ibritumomab tiuxetan 1ethanolamine oleate 1ceritinib 1Whole-Body Irradiation 1Trimethoprim, Sulfamethoxazole Drug Combination 1Trimethoprim 1Triamcinolone Acetonide 1Transplantation 1Thiotepa 1Tacrolimus 1Sulfamethoxazole 1Sodium Chloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Lymphoma, Large-Cell, Anaplastic × Prednisone × Clear all
NCT00513188 2016-12-15

Combination Chemotherapy and Denileukin Diftitox in Treating Patients With Newly Diagnosed T-Cell Non-Hodgkin Lymphoma

University of Miami

Phase NA Withdrawn
DermatologicLymphoid

Immunoblastic Lymphadenopathy, Lymphoma, Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Extranodal NK-T-Cell

NCT00110006 2010-06-11

Positron Emission Tomography Using Fludeoxyglucose F 18 in Predicting Response to Treatment in Patients Who Are Receiving Rituximab and Combination Chemotherapy for Newly Diagnosed Non-Hodgkin's Lymphoma

Case Comprehensive Cancer Center

Phase NA Withdrawn
Lymphoid

Lymphoma, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡